Pfizer

Pfizer

Yahoo Finance • 1 hour ago

Pfizer (PFE) Q3 Earnings Rebuild Confidence As New Drugs Gain Ground

Pfizer just put Q3 2026 on the table and the first instinctive verdict from traders was a modest nod, with the stock up about 2.6% to roughly $30.80 after the release. Headlines are all about a clean return to profitability, with basic ear... Full story

Yahoo Finance • 12 hours ago

BC-Most Active Stocks

NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change Curis Inc. 116,764,683 1.60 1.08 1.195 +0.4811 Helport AI Ltd 105,961,21... Full story

Yahoo Finance • yesterday

Sector Update: Healthcare Stocks Softer Late Afternoon

Healthcare stocks were lower late Tuesday afternoon, with the NYSE Healthcare Index easing 0.2% and Keep reading this article with Yahoo Finance Plus Silver Upgrade to Silver Silver Premium news Full access to Financial Times and MT Ne... Full story

Yahoo Finance • yesterday

Pfizer CEO Touts $80 Billion In Deals — But 'The Real Test' Is Still Ahead

Pfizer beat third-quarter expectations and hiked its guidance Tuesday, but a portfolio manager says "the real test (is) still ahead." Continue Reading... Full story

Yahoo Finance • yesterday

Election Day Trading Splits the Benchmarks, With the Dow Lower and the Nasdaq Higher

NEW YORK, Nov. 3, 2026 /PRNewswire/ -- Equity Insider News Commentary - Tuesday's session reversed the pattern of the day before. On Monday, the Dow Jones Industrial Average was the only one of the four major U.S. stock benchmarks to finis... Full story

Yahoo Finance • 2 days ago

Apple stock falls, chip stocks rebound as oil extends decline: AlphaCheck

Good morning. Stocks rebounded on Tuesday, with chip stocks leading tech (XLK) higher ahead of AMD's (AMD) quarterly results after the close. The rise in tech came despite a decline in Apple (AAPL) shares following the iPhone maker's quar... Full story

Yahoo Finance • 2 days ago

Pfizer Beats And Raises — But 'The Real Test' Is Still Ahead

Pfizer beat third-quarter expectations and hiked its guidance Tuesday, but a portfolio manager says "the real test (is) still ahead." Continue Reading... Full story

Yahoo Finance • 2 days ago

Earnings from AMD and Pfizer plus labor market data: What to Watch

Yahoo Finance Breaking Business News Reporter Jake Conley takes a closer look at the top stories for investors to watch for Tuesday, Nov. 3, including earnings calls from AMD (AMD) and Pfizer (PFE) and data released from the Job Openings a... Full story

Yahoo Finance • 2 days ago

Stock market today: Dow, S&P 500, Nasdaq futures waver ahead of midterm election results, AMD earnings

US stock futures were mixed as Americans went to the polls for the midterm elections and braced for more AI industry earnings from Advanced Micro Devices (AMD). Futures on the Dow Jones Industrial Average (YM=F) fell 0.7%, while those on... Full story

Yahoo Finance • 2 days ago

LG Energy Solution Releases 2026 Third-Quarter Financial Results

LG Energy Solution posts KRW 9.6 trillion in consolidated revenue and KRW 756 billion in operating profit in Q3 2026 Secures new BTM BESS project and high-voltage mid-nickel Gen2 volumes, expanding opportunities across ESS and EV markets T... Full story

Yahoo Finance • 3 days ago

What to expect from Pfizer’s (PFE) Q3 earnings

Global pharmaceutical company Pfizer (NYSE:PFE) will be reporting results this Tuesday before market open. Here's what to expect. Pfizer beat analysts' revenue expectations last quarter, reporting revenues of $15.03 billion, up 2.6% year... Full story

Yahoo Finance • 3 days ago

Quant snapshot: Iovance Biotherapeutics and DiamondRock Hospitality Company lead top-rated names as Intact Financial and Fiserv Payments lag

Quant rankings for the upcoming earnings calendar show strength concentrated across information technology, energy, and health care, while weakness is more pronounced in financials and real estate. A total of 1479 companies are scheduled t... Full story

Yahoo Finance • 3 days ago

Jobs, Midterm Elections, Apple, Palantir, McDonald’s, Moderna, and More to Watch This Week

In another busy earnings week, AMD, Estée Lauder, Qualcomm, Pfizer, and many more will report results. We’ll see three readings on jobs this week, as well as data on the manufacturing and services sectors. Continue Reading... Full story

Yahoo Finance • 4 days ago

A big sell-off collides with more Big Tech earnings and a midterm election: What to watch this week

Last week, we opened the Morning Brief newsletter by saying the first week of Big Tech earnings looked promising — until Thursday. This time, we're here to say the second week of Big Tech earnings looked promising — until Tuesday. Lacklus... Full story

Yahoo Finance • 5 days ago

BridgeBio's Heart Disorder Drug Attruby Faces Unanticipated Near-Term Tailwinds, UBS Says

BridgeBio Pharma's (BBIO) heart disorder drug Attruby faces near-term tailwinds from the likely appr Keep reading this article with Yahoo Finance Plus Silver Upgrade to Silver Silver Premium news Full access to Financial Times and MT N... Full story

Yahoo Finance • 5 days ago

Global Weight Loss Market Size, Share, Trends & Forecast (2026-2036) Featuring Novo Nordisk, Boehringer Ingelheim, Herbalife, WW Int'l, Medtronic and More | GLP-1 Drugs, Oral Therapies, Coverage, and Telehealth Propel Market to $244 Billion by 2036

Company Logo Prioritize oral and multi-pathway drugs, telehealth, public-payer access, direct-to-patient channels, and muscle-preserving nutrition as generics widen global reach Dublin, Oct. 30, 2026 (GLOBE NEWSWIRE) -- "Weight Loss Mark... Full story

Yahoo Finance • 6 days ago

How Investors May Respond To Pfizer (PFE) Phase 3 Cancer Trial Win

Pfizer reported that its Phase 3 MagnetisMM-32 trial of ELREXFIO met the primary endpoint in relapsed or refractory multiple myeloma, while the FDA expanded approval of TALZENNA plus XTANDI for men with metastatic hormone sensitive prostat... Full story

Yahoo Finance • 7 days ago

Global HER2 Targeted Therapies Market Report 2026 | Capitalize on 8.6% CAGR as Pfizer, Roche, AstraZeneca, and Daiichi Sankyo Advance ADCs and Precision Oncology

Company Logo ROI strategies: invest in next-gen ADCs and TKIs, expand biomarker-led and combination therapies, add biosimilars, scale biologics capacity, and pursue acquisitions. Dublin, Oct. 29, 2026 (GLOBE NEWSWIRE) -- "HER2 Targeted T... Full story

Yahoo Finance • 7 days ago

Metaphore Biotechnologies Appoints Frank D’Amelio and Pascal Deschatelets to Board of Directors

D'Amelio has built and reshaped businesses across technology and pharmaceuticals, including nearly 15 years helping lead Pfizer's financial and operational transformation As a serial entrepreneur and inventor, Deschatelets applies scienti... Full story

Yahoo Finance • 7 days ago

Parse Biosciences and Nomic Announce 100 Million Cell, Multimodal AI-ready Dataset for Immune Biology

Licensable perturbation dataset to include transcriptomes and proteomic secretomes for understanding the human immune response SEATTLE & MONTREAL, October 29, 2026--(BUSINESS WIRE)--Parse Biosciences, the leading provider of scalable and... Full story